Abstract Details

Title Botulinum Toxin Type B Clinical Safety in Cervical Dystonia Following up to 4 Years of Treatment

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 155

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
William Birmingham (Solstice Neurosciences)	No disclosure on file
Bilal Butt, MD	Dr. Butt has nothing to disclose.
Eric J. Pappert, MD (Neurology Associates)	No disclosure on file
	No disclosure on file
Edgar F. Salazar-Grueso, MD (Neurobiosciences, LLC)	No disclosure on file

��ɫ����